EE604 Cost-Effectiveness Analysis of Single-Inhaler Triple Therapy (FF/UMEC/VI) in COPD Using the Impact Trial: China Medical Insurance System Perspective
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.869
https://www.valueinhealthjournal.com/article/S1098-3015(23)03999-2/fulltext
Title :
EE604 Cost-Effectiveness Analysis of Single-Inhaler Triple Therapy (FF/UMEC/VI) in COPD Using the Impact Trial: China Medical Insurance System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03999-2&doi=10.1016/j.jval.2023.09.869
First page :
Section Title :
Open access? :
No
Section Order :
10357